Reyataz
Product Images NDC 67296-1236

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 67296-1236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reyataz 300mg (Doc20170511110456 001)

This is a label of Rx drug REYATAZ containing 4 capsules of dosage strength 300mg with Lot number 83239A 1 and expiry date 05/17. The usual adult dosage is available in the package insert provided. The drug is manufactured by Bristol-Myers Squibb Co located in Princeton NJ and distributed by Redpharm Drug Eden Prairie in Minnesota. The NDC number of the drug is 67296-1236-4, and it is advised to store at controlled room temperature between 20-25 C (88-77 F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.